FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
 
Commission File Number 33-55254-42
 
Neuro - Biotech Corp.
(Exact name of registrant as specified in its charter)

Aeschenvorstadt 71, CH-4051, Basel, Switzerland, Telephone: 41 61 500 05 16
 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)
 
Common Shares, $0.001 par value
(Title of each class of securities covered by this Form)
 
NONE
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
Rule 12g-4(a)(1) o
Rule 12g-4(a)(2) þ
Rule 12h-3(b)(1)(i) o
Rule 12h-3(b)(1)(ii) þ
Rule 15d-6 þ
 
Approximate number of holders of record as of the certification or notice  date:  540
 
Pursuant to the requirements of the Securities Exchange Act of 1934 United Mines, Inc.  has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
Date: March 22, 2013
 
By: /s/ William Rusedski
 
    William Rusedski
     
 
Institute of Biomedical ... (PK) (USOTC:MRES)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025 Institute of Biomedical ... (PK) 차트를 더 보려면 여기를 클릭.
Institute of Biomedical ... (PK) (USOTC:MRES)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025 Institute of Biomedical ... (PK) 차트를 더 보려면 여기를 클릭.